These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 38849206

  • 1. Safety of carrageenan-based gels as preventive microbicides: a narrative review.
    Laurie C, El-Zein M, Franco EL.
    Sex Transm Infect; 2024 Aug 19; 100(6):388-394. PubMed ID: 38849206
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of a new carrageenan-based vaginal microbicide in a female population with genital HPV-infection: first experimental results.
    Perino A, Consiglio P, Maranto M, De Franciscis P, Marci R, Restivo V, Manzone M, Capra G, Cucinella G, Calagna G.
    Eur Rev Med Pharmacol Sci; 2019 Aug 19; 23(15):6744-6752. PubMed ID: 31378918
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH, Blanchard K, Chaikummao S, Friedland BA, Srivirojana N, Connolly C, Witwatwongwana P, Supawitkul S, Mock PA, Chaowanachan T, Tappero J.
    Sex Transm Dis; 2008 Mar 19; 35(3):226-32. PubMed ID: 18490865
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Topical microbicides for preventing sexually transmitted infections.
    Obiero J, Ogongo P, Mwethera PG, Wiysonge CS.
    Cochrane Database Syst Rev; 2021 Mar 13; 3(3):CD007961. PubMed ID: 33719075
    [Abstract] [Full Text] [Related]

  • 8. Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa.
    Carraguard Phase II South Africa Study Team.
    Contraception; 2010 Dec 13; 82(6):563-71. PubMed ID: 21074021
    [Abstract] [Full Text] [Related]

  • 9. Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa.
    van de Wijgert JH, Braunstein SL, Morar NS, Jones HE, Madurai L, Strickfaden TT, Moodley M, Aboobaker J, Ndlovu G, Ferguson TM, Friedland BA, Hart CE, Ramjee G.
    J Acquir Immune Defic Syndr; 2007 Dec 15; 46(5):538-46. PubMed ID: 18193495
    [Abstract] [Full Text] [Related]

  • 10. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide.
    Coggins C, Blanchard K, Alvarez F, Brache V, Weisberg E, Kilmarx PH, Lacarra M, Massai R, Mishell D, Salvatierra A, Witwatwongwana P, Elias C, Ellertson C.
    Sex Transm Infect; 2000 Dec 15; 76(6):480-3. PubMed ID: 11221133
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acceptability of a carrageenan-based candidate vaginal microbicide and matching placebo: findings from a phase II safety trial among women in Chiang Rai, Thailand.
    Jones HE, Chaikummao S, van de Wijgert JH, Friedland BA, Manopaiboon C, Witwatwongwana P, Wankrairot M, Chantharojwong N, Kilmarx PH.
    J Womens Health (Larchmt); 2009 Jul 15; 18(7):1003-10. PubMed ID: 19575689
    [Abstract] [Full Text] [Related]

  • 15. First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.
    Friedland BA, Hoesley CJ, Plagianos M, Hoskin E, Zhang S, Teleshova N, Alami M, Novak L, Kleinbeck KR, Katzen LL, Zydowsky TM, Fernández-Romero JA, Creasy GW.
    J Acquir Immune Defic Syndr; 2016 Dec 15; 73(5):489-496. PubMed ID: 27437826
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.
    Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, Dozier G, Maguire R, Lahteenmaki P.
    Lancet; 2008 Dec 06; 372(9654):1977-87. PubMed ID: 19059048
    [Abstract] [Full Text] [Related]

  • 17. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S.
    Contraception; 2008 Feb 06; 77(2):122-9. PubMed ID: 18226677
    [Abstract] [Full Text] [Related]

  • 18. User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.
    Morrow KM, Underhill K, van den Berg JJ, Vargas S, Rosen RK, Katz DF.
    Arch Sex Behav; 2014 Oct 06; 43(7):1459-67. PubMed ID: 24452632
    [Abstract] [Full Text] [Related]

  • 19. Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.
    Whitehead SJ, McLean C, Chaikummao S, Braunstein S, Utaivoravit W, van de Wijgert JH, Mock PA, Siraprapasiri T, Friedland BA, Kilmarx PH, Markowitz LE.
    PLoS One; 2011 Oct 06; 6(9):e14831. PubMed ID: 21915249
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.